MJP Associates Inc. ADV Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

MJP Associates Inc. ADV lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 39.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,955 shares of the healthcare conglomerate’s stock after selling 1,292 shares during the period. MJP Associates Inc. ADV’s holdings in UnitedHealth Group were worth $1,029,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Moneta Group Investment Advisors LLC grew its holdings in UnitedHealth Group by 100,076.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter worth $5,210,004,000. Arrowstreet Capital Limited Partnership grew its holdings in UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Barclays PLC grew its holdings in UnitedHealth Group by 143.4% in the 2nd quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after acquiring an additional 2,058,829 shares during the last quarter. Finally, Morgan Stanley grew its holdings in UnitedHealth Group by 13.8% in the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Truist Financial reaffirmed a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Stock Up 0.2 %

UnitedHealth Group stock traded up $0.83 during trading hours on Wednesday, hitting $493.14. The stock had a trading volume of 2,653,123 shares, compared to its average volume of 4,102,408. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock’s 50-day moving average price is $503.73 and its 200-day moving average price is $518.79. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The stock has a market capitalization of $454.64 billion, a P/E ratio of 20.66, a price-to-earnings-growth ratio of 1.32 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.34 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.